Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
- Submitting institution
-
Institute of Cancer Research: Royal Cancer Hospital (The)
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 185
- Type
- D - Journal article
- DOI
-
10.1093/annonc/mdz396
- Title of journal
- Ann Oncol
- Article number
- -
- First page
- 1992
- Volume
- 30
- Issue
- 12
- ISSN
- 1569-8041
- Open access status
- Compliant
- Month of publication
- December
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
https://www.sciencedirect.com/science/article/pii/S0923753420325527?via%3Dihub#ec0010
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
49
- Research group(s)
-
-
- Citation count
- 60
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
